Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin

被引：0
|
作者：
Lembo, Anthony J. [1 ]
Heimanson, Zeev [2 ]
Pimentel, Mark [3 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00444
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
444
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [1] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Lembo, Anthony J.
    Rao, Satish
    Wolf, Ray
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [2] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [3] Stool microbiota characterization in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) receiving repeat Rifaximin
    Pimentel, M.
    Fodor, A. A.
    Golden, P. L.
    Bortey, E.
    Forbes, W. P.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 100 - 100
  • [4] Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment
    Pimentel, Mark
    Lembo, Anthony J.
    Wolf, Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S240 - S240
  • [5] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials
    Pimentel, Mark
    Cash, Brooks D.
    Wolf, Ray
    Lembo, Anthony J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254
  • [6] Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Chey, William D.
    Lembo, Anthony J.
    Wolf, Ray A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S750 - S751
  • [7] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT
    Pimentel, Mark
    Schoenfeld, Phillip
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S500
  • [8] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    [J]. GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [9] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [10] Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    Kane, John S.
    Ford, Alexander C.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (04) : 431 - 442
12345